Incontinence and Ostomy Care Global Market-Forecast to 2026

Publishing Date : August, 2020
Report Code : HCMD0143
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Note: The report would be dispatched after confirmation of payment

 

Incontinence and Ostomy Care consist of products that are essential for patients with incontinence and stoma surgeries. Increasing in aged population, increased utilization of the various incontinence and ostomy care products for the management or treatment of different types of incontinence and ostomy surgeries among the patients, elevating inclination of the value centric global patient pool towards the technologically advanced incontinence and ostomy care products with better therapeutic outcomes and also increasing awareness about the disease and the availability of the wide varieties of products to manage or treat the disease conditions fuelling the incontinence and ostomy care global market.

As estimated by IQ4I Research, the incontinence and ostomy care global market is expected to reach $24,577.9 million by 2026 growing at a mid single digit from 2019 to 2026 due to increase in population prone to aging related medical conditions, growing prevalence of medical conditions such as women health related conditions (e.g. childbirth, menopause), inflammatory bowel diseases (crohn’s disease and ulcerative colitis), neurological diseases (multiple sclerosis, Parkinson’s disease), oncology (colorectal and prostate cancer) and others diseases, increasing awareness & acceptance of the condition of incontinence & ostomy, growing economies and increasing demand for better healthcare facilities in emerging markets. The incontinence and ostomy market is segmented by product, utility, application, end-user and geography.

Based on the product type, the incontinence and ostomy care global market is segmented into incontinence and ostomy care. Incontinence care segment is the largest and fastest growing product segment is expected to grow at a mid single digit CAGR from 2019 to 2026. Based on disease type, the incontinence care market is classified into urinary incontinence and fecal incontinence, urinary incontinence is accounted for largest and fastest growing segment is expected to grow at a mid single digit CAGR from 2019 to 2026. Based on the product type, incontinence care market is segment into disposables and implantable device. Among these segments, disposables segment accounted for the largest revenue in 2019 and it is expected to grow at a mid single digit CAGR from 2019 to 2026. Implant devices is fastest growing segment at a high single digit CAGR from 2019 to 2026. In the disposable global market by type, the adult diapers segment holds the highest revenue in 2019 and it is expected to grow at a mid single digit from 2019 to 2026. Incontinence Catheter is fastest growing segment at a mid single digit CAGR from 2019 to 2026. Among the overall adult diaper market by type, underwear & briefs segment holds the highest revenue in 2019 and it is expected to grow at a mid single digit CAGR from 2019 to 2026. Pads & Guards is fastest growing segment at a mid single digit CAGR from 2019 to 2026. Implant devices by product type, Sacral Nerve Stimulation (SNS) segment holds the highest revenue in 2019 and it is expected to grow at a mid single digit CAGR from 2019 to 2026. Slings is fastest growing segment at a CAGR of high single digit from 2019 to 2026.

Ostomy care is growing at low single digit from 2019 to 2026. The ostomy care global market by surgery type, colostomy segment is the largest and fastest growing product segment expected to grow at low single digit CAGR from 2019 to 2026 due to increase prevalence of targeted diseases such as cancer and GI tract diseases. Based on product type the ostomy care global market is classified into ostomy bags, skin barriers, deodorants, irrigation products and others accessories like ostomy tape, removers, belts, detergents, stoma implants and stoma caps. The ostomy bags segment is the largest and fastest growing product segment and expected to grow at low single digit CAGR from 2019 to 2026. Among the ostomy bags, two-piece ostomy bags is the largest and fastest growing segment and expected to grow at mid single digit CAGR from 2019 to 2026 due to technological innovations in their designs.

Based on the utility, the incontinence and ostomy care global market is segmented into security & leakage control, protection & cleansing, odor control and irrigation products. Security & Leakage control segment is the largest and fastest growing segment and expected to grow at mid single digit CAGR from 2019 to 2026 due to increasing use of security and leakage control device for incontinence and stoma management and increasing technological advancement in these devices to increase efficiency.

Based on application, the incontinence and ostomy global market is segmented into women health related, neurological conditions, oncology, urinogenital diseases, GI Tract diseases and others. Women health related segment accounted for the largest revenue in 2019 and is expected to grow at mid single digit CAGR from 2019 to 2026 due to women are more prone to incontinence related problems such as damage to nerve controlling urine or fecal urge during childbirth and impaired sphincter function which is a result of pelvic floor weakness which in turn may be due to pregnancy & vaginal birth, surgeries related to uterus, aging and weakness of the connective tissue. Oncology segment is the fastest growing segment and is projected to grow at mid single digit CAGR from 2019 to 2026 due to increase in the prevalence of prostate, colorectal and bladder cancers.

Based on end-users of incontinence and ostomy care market has been segmented into hospitals, home care, and others that consist of clinics and research institutes. Homecare accounted for the largest revenue in 2019 and it expected to grow at mid single digit CAGR from 2019 to 2026 due to the availability of better and technologically advanced personalized incontinence and stoma management products. The hospitals is fastest growing segment and is projected to grow at a mid single digit CAGR from 2019 to 2026 due to increasing availability various advanced minimally invasive treatments.

Based on the region, the incontinence and ostomy care global market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, U.K and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of APAC) and Rest of the world (Brazil, Rest of Latin America and Middle East & Africa). Europe accounted for the largest revenue in 2019 and is expected to growing at a low single digit CAGR from 2019 to 2026 due to increasing prevalence of targeted disease in the region, escalating geriatric population, increasing penetration and adoption of advanced products and increasing R&D spending for developing innovative and technologically advanced products.

The Asia-Pacific is the fastest growing region in incontinence and ostomy care market and is expected to grow at a high single digit CAGR from 2019 to 2026 due to elevating increasing geriatric population, increasing demand for better healthcare facilities, increasing penetration of reimbursement schemes in developing countries, elevating demand for better healthcare facilities from the population in the region and growing economies of the region, availability of various kinds of incontinence and ostomy management products and increasing medical tourism prospects of the region.  

Some of the major players in incontinence and ostomy care market include Essity AB (Sweden), Coloplast A/S (Denmark), Kimberly-Clark Corporation (U.S.), Unicharm Corporation (Japan), ConvaTec Group Plc (U.K.), B. Braun Melsungen AG (Germany), Medtronic Plc (Ireland), Ontex (Belgium), Paul Hartmann AG (Germany), Procter & Gamble Company (U.S.), Hollister Incorporated (U.S.), Salts Healthcare (U.K.), First Quality Enterprises, Inc. (U.S.), Abena A/S (Denmark), Becton, Dickinson and Company (U.S.), Medline Industries, Inc., (U.S.), Domtar Corporation (U.S.) and others.

 

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
  • U.S.
  • Rest of North America
  • Europe
  • Germany
  • U.K.
  • France
  • Rest of Europe
  • Asia-Pacific 
  • Japan
  • China
  • Indian
  • Rest of APAC
  • Rest of the World (RoW)
  • Brazil
  • Rest of LATAM
  • Middle East and Africa
  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     SCOPE OF THE REPORT
    • 2.3     REPORT DESCRIPTION
    • 2.4     MARKETS COVERED
    • 2.5     STAKEHOLDERS
    • 2.6     RESEARCH METHODOLOGY
      • 2.6.1     MARKET SIZE ESTIMATION
      • 2.6.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.6.3     SECONDARY SOURCES
      • 2.6.4     PRIMARY SOURCES
      • 2.6.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.6.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.6.7     ASSUMPTIONS
        • 2.6.7.1     AVERAGE SELLING PRICE ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     INCREASE IN AGING POPULATION
        • 3.3.1.2     DEVELOPMENT OF INNOVATIVE AND PERSONALIZED PRODUCTS
        • 3.3.1.3     INCREASE IN AWARENESS AND ACCEPTANCE
        • 3.3.1.4     INCREASE IN PREVALENCE OF CHRONIC DISEASES
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     ENVIRONMENT AND DISPOSAL CONCERNS
        • 3.3.2.2     LOW COST MANUFACTURES
        • 3.3.2.3     ALTERNATIVE MEDICAL TREATMENT
        • 3.3.2.4     LIMITED REIMBURSEMENT
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1.1     ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM
      • 3.4.1.2     ISO 13485 MEDICAL DEVICES
      • 3.4.1.3     ISO 10993 BIOLOGICAL EVALUATION OF MEDICAL DEVICES
      • 3.4.1.4     ISO 14971 RISK MANAGEMENT OF MEDICAL DEVICES
      • 3.4.1.5     IEC 60601-1 MEDICAL ELECTRICAL EQUIPMENT STANDARD
      • 3.4.1.6     IEC 60601-1-11 HOME CARE SAFETY
    • 3.4.2     U.S.
    • 3.4.3     EUROPE
    • 3.4.4     JAPAN
    • 3.4.5     CHINA
    • 3.4.6     INDIA
  • 3.5     PATENT ANALYSIS
  • 3.6     TECHNOLOGICAL ADVANCEMENTS
    • 3.6.1     SMART DIAPERS
    • 3.6.2     SMART BAGS
    • 3.6.3     WEARBLE DIAPER FREE DEVICES (DFREE)
    • 3.6.4     WEARBLE PELVIC FLOOR MUSCLE STIMULATION DEVICES
    • 3.6.5     ADVANCEMENTS IN BIOMATERIALS
    • 3.6.6     INCREASED ABSORBENCE AND ANTIBACTERIAL SOLUTIONS
    • 3.6.7     MOLDABLE TECHNOLOGY
    • 3.6.8     NEXT GENERATION OSTOMY IMPLANTS
  • 3.7     PORTER’S FIVE FORCE ANALYSIS
    • 3.7.1     THREAT OF NEW ENTRANTS
    • 3.7.2     THREAT OF SUBSTITUTES
    • 3.7.3     BARGAINING POWER OF SUPPLIERS
    • 3.7.4     BARGAINING POWER OF BUYERS
    • 3.7.5     COMPETITIVE RIVALRY
  • 3.8     SUPPLY CHAIN ANALYSIS
  • 3.9     REIMBURSEMENT SCENARIO
  • 3.10     PIPELINE ANALYSIS
  • 3.11     INCONTINENCE AND OSTOMY CARE MARKET PENETRATION, PREVALENCE AND OPPORTUNITY
    • 3.11.1     ADULT DIAPERS MARKET PENETRATION, PREVALENCE AND OPPORTUNITY
    • 3.11.2     OSTOMY MARKET PENETRATION, PREVALENCE AND OPPORTUNITY
  • 3.12     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
    • 3.12.1     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET SHARE ANALYSIS
    • 3.12.2     INCONTINENCE CARE GLOBAL MARKET SHARE ANALYSIS
    • 3.12.3     OSTOMY CARE GLOBAL MARKET SHARE ANALYSIS
    • 3.12.4     ADULT DIAPERS GLOBAL MARKET SHARE ANALYSIS
      • 3.12.4.1     NORTH AMERICA ADULT DIAPERS MARKET SHARE ANALYSIS
      • 3.12.4.2     EUROPE ADULT DIAPERS MARKET SHARE ANALYSIS
      • 3.12.4.3     ASIA-PACIFIC ADULT DIAPERS MARKET SHARE ANALYSIS
      • 3.12.4.4     REST OF THE WORLD ADULT DIAPERS MARKET SHARE ANALYSIS
  • 3.13     INCONTINENCE AND OSTOMY CARE COMPANY COMPARISON TABLE BY PRODUCT TYPE, PRODUCT NAME AND APPLICATION
  • 4     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET, BY PRODUCT
    • 4.1     INTRODUCTION
    • 4.2     INCONTINENCE CARE
      • 4.2.1     INCONTINENCE CARE GLOBAL MARKET BY DISEASE TYPE
        • 4.2.1.1     URINARY INCONTINENCE
        • 4.2.1.2     FECAL INCONTINENCE
      • 4.2.2     INCONTINENCE CARE GLOBAL MARKET BY PRODUCT TYPE
        • 4.2.2.1     DISPOSABLES
          • 4.2.2.1.1      ADULT DIAPER
            • 4.2.2.1.1.1      UNDERWEAR & BRIEFS
            • 4.2.2.1.1.2      PADS & GUARDS
            • 4.2.2.1.1.3      LINERS & DRIP COLLECTION (SHIELDS)
            • 4.2.2.1.1.4      OTHER ADULT DIAPERS
          • 4.2.2.1.2      INCONTINENCE CATHETER
          • 4.2.2.1.3      INCONTINENCE BAGS
          • 4.2.2.1.4      ANAL IRRIGATION SYSTEM
          • 4.2.2.1.5      PESSARIES
          • 4.2.2.1.6      OTHER DISPOSABLES
        • 4.2.2.2     IMPLANT DEVICES
          • 4.2.2.2.1      SACRAL NERVE STIMULATION (SNS)
          • 4.2.2.2.2      TIBIAL NERVE STIMULATION (TNS)
          • 4.2.2.2.3      ARTIFICIAL SPHINCTERS
          • 4.2.2.2.4      SLINGS
    • 4.3     OSTOMY CARE
      • 4.3.1     OSTOMY CARE GLOBAL MARKET BY SURGERY TYPE
        • 4.3.1.1     COLOSTOMY
        • 4.3.1.2     ILEOSTOMY
        • 4.3.1.3     UROSTOMY
      • 4.3.2     OSTOMY CARE GLOBAL MARKET BY PRODUCT TYPE
        • 4.3.2.1     OSTOMY BAGS
          • 4.3.2.1.1      ONE-PIECE OSTOMY BAGS
          • 4.3.2.1.2      TWO-PIECE OSTOMY BAGS
        • 4.3.2.2     SKIN BARRIER
        • 4.3.2.3     DEODORANT
        • 4.3.2.4     IRRIGATION PRODUCTS
        • 4.3.2.5     OTHER OSTOMY CARE
  • 5     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET, BY UTILITY
    • 5.1     INTRODUCTION
    • 5.2     SECURITY AND LEAKAGE CONTROL
    • 5.3     ODOR CONTROL
    • 5.4     PROTECTION AND CLEANSING
    • 5.5     IRRIGATION PRODUCTS
  • 6     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET, BY APPLICATION
    • 6.1     INTRODUCTION
    • 6.2     WOMEN HEALTH RELATED
    • 6.3     GI TRACT DISEASES
    • 6.4     ONCOLOGY
    • 6.5     NEUROLOGICAL CONDITIONS
    • 6.6     URINOGENITAL DISEASES
    • 6.7     OTHER DISEASES
  • 7     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET, BY END-USER
    • 7.1     INTRODUCTION
    • 7.2     HOSPITALS
    • 7.3     HOMECARE
    • 7.4     OTHER END-USER
  • 8     REGIONAL ANALYSIS
    • 8.1     INTRODUCTION
    • 8.2     NORTH AMERICA
      • 8.2.1     U.S.
      • 8.2.2     REST OF NORTH AMERICA
    • 8.3     EUROPE
      • 8.3.1     GERMANY
      • 8.3.2     FRANCE
      • 8.3.3     U.K.
      • 8.3.4     REST OF EUROPE
    • 8.4     APAC
      • 8.4.1     JAPAN
      • 8.4.2     CHINA
      • 8.4.3     INDIA
      • 8.4.4     REST OF APAC
    • 8.5     ROW
      • 8.5.1     BRAZIL
      • 8.5.2     REST OF LATAM
      • 8.5.3     MIDDLE EAST & AFRICA
  • 9     COMPETITIVE LANDSCAPE
    • 9.1     INTRODUCTION
    • 9.2     ACQUISITION AND PARTNERSHIP
    • 9.3     PRODUCT LAUNCH
    • 9.4     PRODUCT APPROVAL
    • 9.5     OTHERS
  • 10     MAJOR COMPANIES
    • 10.1     COLOPLAST A/S
      • 10.1.1     OVERVIEW
      • 10.1.2     FINANCIALS
      • 10.1.3     PRODUCT PORTFOLIO
      • 10.1.4     KEY DEVELOPMENTS
      • 10.1.5     BUSINESS STRATEGY
      • 10.1.6     SWOT ANALYSIS
    • 10.2     CONVATEC GROUP PLC
      • 10.2.1     OVERVIEW
      • 10.2.2     FINANCIALS
      • 10.2.3     PRODUCT PORTFOLIO
      • 10.2.4     KEY DEVELOPMENTS
      • 10.2.5     BUSINESS STRATEGY
      • 10.2.6     SWOT ANALYSIS
    • 10.3     DOMTAR CORPORATION
      • 10.3.1     OVERVIEW
      • 10.3.2     FINANCIALS
      • 10.3.3     PRODUCT PORTFOLIO
      • 10.3.4     KEY DEVELOPMENTS
      • 10.3.5     BUSINESS STRATEGY
      • 10.3.6     SWOT ANALYSIS
    • 10.4     ESSITY AKTIEBOLAG (PUBL)
      • 10.4.1     OVERVIEW
      • 10.4.2     FINANCIALS
      • 10.4.3     PRODUCT PORTFOLIO
      • 10.4.4     KEY DEVELOPMENTS
      • 10.4.5     BUSINESS STRATEGY
      • 10.4.6     SWOT ANALYSIS
    • 10.5     HOLLISTER INCORPORATED
      • 10.5.1     OVERVIEW
      • 10.5.2     FINANCIALS
      • 10.5.3     PRODUCT PORTFOLIO
      • 10.5.4     KEY DEVELOPMENTS
      • 10.5.5     BUSINESS STRATEGY
      • 10.5.6     SWOT ANALYSIS
    • 10.6     KIMBERLY-CLARK CORPORATION
      • 10.6.1     OVERVIEW
      • 10.6.2     FINANCIALS
      • 10.6.3     PRODUCT PORTFOLIO
      • 10.6.4     KEY DEVELOPMENTS
      • 10.6.5     BUSINESS STRATEGY
      • 10.6.6     SWOT ANALYSIS
    • 10.7     MEDTRONIC, PLC.
      • 10.7.1     OVERVIEW
      • 10.7.2     FINANCIALS
      • 10.7.3     PRODUCT PORTFOLIO
      • 10.7.4     KEY DEVELOPMENTS
      • 10.7.5     BUSINESS STRATEGY
      • 10.7.6     SWOT ANALYSIS
    • 10.8     ONTEX
      • 10.8.1     OVERVIEW
      • 10.8.2     FINANCIALS
      • 10.8.3     PRODUCT PORTFOLIO
      • 10.8.4     KEY DEVELOPMENTS
      • 10.8.5     BUSINESS STRATEGY
      • 10.8.6     SWOT ANALYSIS
    • 10.9     PAUL HARTMANN AG
      • 10.9.1     OVERVIEW
      • 10.9.2     FINANCIALS
      • 10.9.3     PRODUCT PORTFOLIO
      • 10.9.4     KEY DEVELOPMENTS
      • 10.9.5     BUSINESS STRATEGY
      • 10.9.6     SWOT ANALYSIS
    • 10.10     UNICHARM CORPORATION
      • 10.10.1     OVERVIEW
      • 10.10.2     FINANCIALS
      • 10.10.3     PRODUCT PORTFOLIO
      • 10.10.4     KEY DEVELOPMENTS
      • 10.10.5     BUSINESS STRATEGY
      • 10.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 2     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 3     INCONTINENCE CARE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 4     INCONTINENCE CARE GLOBAL MARKET REVENUE, BY DISEASE TYPE, (2018-2026) ($MN)
      • TABLE 5     URINARY INCONTINENCE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 6     FECAL INCONTINENCE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 7     INCONTINENCE CARE GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
      • TABLE 8     DISPOSABLES GLOBAL MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
      • TABLE 9     DISPOSABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 10     ADULT DIAPER GLOBAL MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
      • TABLE 11     ADULT DIAPER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 12     UNDERWEAR & BRIEFS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 13     PADS & GUARDS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 14     LINERS & DRIP COLLECTION (SHIELDS) GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 15     OTHER ADULT DIAPERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 16     INCONTINENCE CATHETER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 17     INCONTINENCE BAGS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 18     ANAL IRRIGATION SYSTEM GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 19     PESSARIES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 20     OTHER DISPOSABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 21     IMPLANT DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
      • TABLE 22     IMPLANT DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 23     SACRAL NERVE STIMULATION (SNS) GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 24     TIBIAL NERVE STIMULATION (TNS) GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 25     ARTIFICIAL SPHINCTERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 26     SLINGS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 27     OSTOMY CARE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 28     OSTOMY CARE GLOBAL MARKET REVENUE, BY SURGERY TYPE, (2018-2026) ($MN)
      • TABLE 29     COLOSTOMY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 30     ILEOSTOMY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 31     UROSTOMY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 32     OSTOMY CARE GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
      • TABLE 33     OSTOMY BAGS GLOBAL MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
      • TABLE 34     ONE-PIECE OSTOMY BAGS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 35     TWO-PIECE OSTOMY BAGS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 36     SKIN BARRIER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 37     DEODORANT GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 38     IRRIGATION PRODUCTS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 39     OTHER OSTOMY CARE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 40     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET REVENUE, BY UTILITY, (2018-2026) ($MN)
      • TABLE 41     SECURITY AND LEAKAGE CONTROL GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 42     ODOR CONTROL GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 43     PROTECTION AND CLEANSING GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 44     IRRIGATION PRODUCTS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 45     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
      • TABLE 46     WOMEN HEALTH RELATED GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 47     GI TRACT DISEASES GLOBAL MARKET REVENUE BY REGION, (2018-2026) ($MN)
      • TABLE 48     ONCOLOGY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 49     NEUROLOGICAL CONDITIONS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 50     URINOGENITAL DISEASES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 51     OTHER DISEASES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 52     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
      • TABLE 53     HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 54     HOMECARE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 55     OTHER END-USER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 56     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 57     NORTH AMERICA INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 58     NORTH AMERICA INCONTINENCE CARE MARKET REVENUE, BY DISEASE TYPE, (2018-2026) ($MN)
      • TABLE 59     NORTH AMERICA INCONTINENCE CARE MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
      • TABLE 60     NORTH AMERICA DISPOSABLE MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
      • TABLE 61     NORTH AMERICA ADULT DIAPER MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
      • TABLE 62     NORTH AMERICA IMPLANT DEVICES MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
      • TABLE 63     NORTH AMERICA OSTOMY CARE MARKET REVENUE, BY SURGERY TYPE, (2018-2026) ($MN)
      • TABLE 64     NORTH AMERICA OSTOMY CARE MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
      • TABLE 65     NORTH AMERICA OSTOMY BAGS MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
      • TABLE 66     NORTH AMERICA INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY UTILITY, (2018-2026) ($MN)
      • TABLE 67     NORTH AMERICA INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
      • TABLE 68     NORTH AMERICA INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
      • TABLE 69     NORTH AMERICA INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
      • TABLE 70     EUROPE INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 71     EUROPE INCONTINENCE CARE MARKET REVENUE, BY DISEASE TYPE, (2018-2026) ($MN)
      • TABLE 72     EUROPE INCONTINENCE CARE MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
      • TABLE 73     EUROPE DISPOSABLE MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
      • TABLE 74     EUROPE ADULT DIAPER MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
      • TABLE 75     EUROPE IMPLANT DEVICES MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
      • TABLE 76     EUROPE OSTOMY CARE MARKET REVENUE, BY SURGERY TYPE, (2018-2026) ($MN)
      • TABLE 77     EUROPE OSTOMY CARE MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
      • TABLE 78     EUROPE OSTOMY BAGS MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
      • TABLE 79     EUROPE INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY UTILITY, (2018-2026) ($MN)
      • TABLE 80     EUROPE INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
      • TABLE 81     EUROPE INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
      • TABLE 82     EUROPE INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
      • TABLE 83     APAC INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 84     APAC INCONTINENCE CARE MARKET REVENUE, BY DISEASE TYPE, (2018-2026) ($MN)
      • TABLE 85     APAC INCONTINENCE CARE MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
      • TABLE 86     APAC DISPOSABLE MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
      • TABLE 87     APAC ADULT DIAPER MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
      • TABLE 88     APAC IMPLANT DEVICES MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
      • TABLE 89     APAC OSTOMY CARE MARKET REVENUE, BY SURGERY TYPE, (2018-2026) ($MN)
      • TABLE 90     APAC OSTOMY CARE MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
      • TABLE 91     APAC OSTOMY BAGS MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
      • TABLE 92     APAC INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY UTILITY, (2018-2026) ($MN)
      • TABLE 93     APAC INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
      • TABLE 94     APAC INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
      • TABLE 95     APAC INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
      • TABLE 96     ROW INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
      • TABLE 97     ROW INCONTINENCE CARE MARKET REVENUE, BY DISEASE TYPE, (2018-2026) ($MN)
      • TABLE 98     ROW INCONTINENCE CARE MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
      • TABLE 99     ROW DISPOSABLE MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
      • TABLE 100     ROW ADULT DIAPER MARKET REVENUE, BY TYPE (2018-2026) ($MN)
      • TABLE 101     ROW IMPLANT DEVICES MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
      • TABLE 102     ROW OSTOMY CARE MARKET REVENUE, BY SURGERY TYPE, (2018-2026) ($MN)
      • TABLE 103     ROW OSTOMY CARE MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
      • TABLE 104     ROW OSTOMY BAGS MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
      • TABLE 105     ROW INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY UTILITY, (2018-2026) ($MN)
      • TABLE 106     ROW INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
      • TABLE 107     ROW INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
      • TABLE 108     ROW INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
      • TABLE 109     ACQUISITION AND PARTNERSHIP (2017-2020)
      • TABLE 110     PRODUCT LAUNCH (2017-2020)
      • TABLE 111     PRODUCT APPROVAL (2017-2020)
      • TABLE 112     OTHERS (2017-2020)
      • TABLE 113     COLOPLAST: TOTAL SALES AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 114     COLOPLAST: TOTAL SALES, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 115     COLOPLAST: TOTAL SALES, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 116     CONVATEC GROUP PLC: TOTAL SALES AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 117     CONVATEC GROUP PLC: TOTAL SALES, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 118     CONVATEC GROUP PLC: TOTAL SALES, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 119     DOMTAR CORPORATION: TOTAL SALES AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 120     DOMTAR CORPORATION: TOTAL SALES, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 121     DOMTAR CORPORATION: TOTAL SALES, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 122     ESSITY AKTIEBOLAG (PUBL): TOTAL SALES AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 123     ESSITY AKTIEBOLAG (PUBL): TOTAL SALES, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 124     ESSITY AKTIEBOLAG (PUBL): TOTAL SALES, BY SUB-SEGMENTS, (2017-2019) ($MN)
      • TABLE 125     ESSITY AKTIEBOLAG (PUBL): TOTAL SALES, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 126     KIMBERLY-CLARK CORPORATION: TOTAL SALES AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 127     KIMBERLY-CLARK CORPORATION: TOTAL SALES, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 128     KIMBERLY-CLARK CORPORATION: TOTAL SALES, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 129     MEDTRONIC, PLC: TOTAL SALES AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 130     MEDTRONIC, PLC: TOTAL SALES, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 131     MEDTRONIC, PLC: TOTAL SALES, BY SUB-SEGMENTS, (2017-2019) ($MN)
      • TABLE 132     MEDTRONIC, PLC: TOTAL SALES, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 133     ONTEX: TOTAL SALES AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 134     ONTEX: TOTAL SALES, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 135     ONTEX: TOTAL SALES, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 136     PAUL HARTMANN AG: TOTAL SALES AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 137     PAUL HARTMANN AG: TOTAL SALES, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 138     PAUL HARTMANN AG: TOTAL SALES, BY GEOGRAPHY, (2017-2019) ($MN)
      • TABLE 139     UNICHARM CORPORATION: TOTAL SALES AND R&D EXPENSES, (2017-2019) ($MN)
      • TABLE 140     UNICHARM CORPORATION: TOTAL SALES, BY SEGMENTS, (2017-2019) ($MN)
      • TABLE 141     UNICHARM CORPORATION: TOTAL SALES, BY GEOGRAPHY, (2017-2019) ($MN)

      LIST OF FIGURES

      • FIGURE 1     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: INCONTINENCE AND OSTOMY CARE GLOBAL MARKET
      • FIGURE 3     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
      • FIGURE 6     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     INCONTINENCE AND OSTOMY CARE: PATENT ANALYSIS (2015-2020)
      • FIGURE 9     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 10     INCONTINENCE AND OSTOMY CARE: SUPPLY CHAIN ANALYSIS
      • FIGURE 11     GLOBAL ADULT DIAPER MARKET PENETRATION, OPPORTUNITY AND NUMBER OF ADULT DIAPER CONSUMPTION, (2020)
      • FIGURE 12     NORTH AMERICA ADULT DIAPER MARKET PENETRATION, OPPORTUNITY AND NUMBER OF ADULT DIAPER CONSUMPTION, (2020)
      • FIGURE 13     EUROPE ADULT DIAPER MARKET PENETRATION, OPPORTUNITY AND NUMBER OF ADULT DIAPER CONSUMPTION, (2020)
      • FIGURE 14     ASIA-PACIFIC ADULT DIAPER MARKET PENETRATION, OPPORTUNITY AND NUMBER OF ADULT DIAPER CONSUMPTION, (2020)
      • FIGURE 15     ROW ADULT DIAPER MARKET PENETRATION, OPPORTUNITY AND NUMBER OF ADULT DIAPER CONSUMPTION, (2020)
      • FIGURE 16     GLOBAL COLOSTOMY MARKET PENETRATION, OPPORTUNITY AND NUMBER OF OSTOMY BAGS CONSUMPTION, (2020)
      • FIGURE 17     NORTH AMERICA COLOSTOMY MARKET PENETRATION, OPPORTUNITY AND NUMBER OF OSTOMY BAGS CONSUMPTION, (2020)
      • FIGURE 18     EUROPE COLOSTOMY MARKET PENETRATION, OPPORTUNITY AND NUMBER OF OSTOMY BAGS CONSUMPTION, (2020)
      • FIGURE 19     ASIA-PACIFIC COLOSTOMY MARKET PENETRATION, OPPORTUNITY AND NUMBER OF OSTOMY BAGS CONSUMPTION, (2020)
      • FIGURE 20     ROW COLOSTOMY MARKET PENETRATION, OPPORTUNITY AND NUMBER OF OSTOMY BAGS CONSUMPTION, (2020)
      • FIGURE 21     GLOBAL ILEOSTOMY MARKET PENETRATION, OPPORTUNITY AND NUMBER OF OSTOMY BAGS CONSUMPTION, (2020)
      • FIGURE 22     NORTH AMERICA ILEOSTOMY MARKET PENETRATION, OPPORTUNITY AND NUMBER OF OSTOMY BAGS CONSUMPTION, (2020)
      • FIGURE 23     EUROPE ILEOSTOMY MARKET PENETRATION, OPPORTUNITY AND NUMBER OF OSTOMY BAGS CONSUMPTION, (2020)
      • FIGURE 24     ASIA-PACIFIC ILEOSTOMY MARKET PENETRATION, OPPORTUNITY AND NUMBER OF OSTOMY BAGS CONSUMPTION, (2020)
      • FIGURE 25     ROW ILEOSTOMY MARKET PENETRATION, OPPORTUNITY AND NUMBER OF OSTOMY BAGS CONSUMPTION, (2020)
      • FIGURE 26     GLOBAL UROSTOMY MARKET PENETRATION, OPPORTUNITY AND NUMBER OF OSTOMY BAGS CONSUMPTION, (2020)
      • FIGURE 27     NORTH AMERICA UROSTOMY MARKET PENETRATION, OPPORTUNITY AND NUMBER OF OSTOMY BAGS CONSUMPTION, (2020)
      • FIGURE 28     EUROPE UROSTOMY MARKET PENETRATION, OPPORTUNITY AND NUMBER OF OSTOMY BAGS CONSUMPTION, (2020)
      • FIGURE 29     ASIA-PACIFIC UROSTOMY MARKET PENETRATION, OPPORTUNITY AND NUMBER OF OSTOMY BAGS CONSUMPTION, (2020)
      • FIGURE 30     ROW UROSTOMY MARKET PENETRATION, OPPORTUNITY AND NUMBER OF OSTOMY BAGS CONSUMPTION, (2020)
      • FIGURE 31     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2019 (%)
      • FIGURE 32     INCONTINENCE CARE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2019 (%)
      • FIGURE 33     OSTOMY CARE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2019 (%)
      • FIGURE 34     ADULT DIAPERS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2019 (%)
      • FIGURE 35     NORTH AMERICA ADULT DIAPERS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2019 (%)
      • FIGURE 36     EUROPE ADULT DIAPERS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2019 (%)
      • FIGURE 37     APAC ADULT DIAPERS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2019 (%)
      • FIGURE 38     ROW ADULT DIAPERS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2019 (%)
      • FIGURE 39     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 40     INCONTINENCE CARE GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 41     INCONTINENCE CARE GLOBAL MARKET SHARE, BY DISEASE TYPE (2019 V/S 2026) (%)
      • FIGURE 42     URINARY INCONTINENCE GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 43     FECAL INCONTINENCE GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 44     INCONTINENCE CARE GLOBAL MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) (%)
      • FIGURE 45     DISPOSABLES GLOBAL MARKET SHARE, BY TYPE (2019 V/S 2026) (%)
      • FIGURE 46     DISPOSABLES GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 47     ADULT DIAPER GLOBAL MARKET SHARE, BY TYPE (2019 V/S 2026) (%)
      • FIGURE 48     ADULT DIAPER GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 49     PADS & GUARDS GLOBAL MARKET REVENUE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 50     INCONTINENCE CATHETER GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 51     IMPLANT DEVICES GLOBAL MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) (%)
      • FIGURE 52     OSTOMY CARE GLOBAL MARKET SHARE, BY SURGERY TYPE (2019 V/S 2026) (%)
      • FIGURE 53     OSTOMY CARE GLOBAL MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) (%)
      • FIGURE 54     OSTOMY BAGS GLOBAL MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) (%)
      • FIGURE 55     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET SHARE, BY UTILITY (2019 V/S 2026) (%)
      • FIGURE 56     SECURITY AND LEAKAGE CONTROL GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 57     PROTECTION AND CLEANSING GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 58     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
      • FIGURE 59     GI TRACT DISEASES GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 60     NEUROLOGICAL CONDITIONS GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 61     OTHER DISEASES GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 62     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
      • FIGURE 63     HOMECARE GLOBAL MARKET REVENUE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 64     OTHER END-USER GLOBAL MARKET REVENUE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 65     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN), CAGR (%)
      • FIGURE 66     INCONTINENCE AND OSTOMY CARE GLOBAL MARKET SHARE, BY REGION AND MARKET REVENUE BY COUNTRY (2019) (%) ($MN)
      • FIGURE 67     NORTH AMERICA INCONTINENCE AND OSTOMY CARE MARKET SHARE, BY PRODUCT, UTILITY, APPLICATION AND END-USER (2019 V/S 2026) (%)
      • FIGURE 68     NORTH AMERICA INCONTINENCE CARE MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) AND DISPOSABLE, ADULT DIAPER, IMPLANT DEVICES, BY TYPE (2019) (%)
      • FIGURE 69     NORTH AMERICA INCONTINENCE CARE MARKET SHARE, BY DISEASE TYPE AND OSTOMY CARE, BY SURGERY TYPE (2019 V/S 2026) (%)
      • FIGURE 70     NORTH AMERICA OSTOMY CARE MARKET SHARE, BY PRODUCT TYPE AND OSTOMY BAGS, BY TYPE (2019 V/S 2026) (%)
      • FIGURE 71     NORTH AMERICA INCONTINENCE AND OSTOMY CARE MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
      • FIGURE 72     U.S. INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY PRODUCT AND INCONTINENCE CARE, BY PRODUCT TYPE (2019 V/S 2026) ($MN)
      • FIGURE 73     U.S. INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY UTILITY AND END-USER (2019 V/S 2026) ($MN)
      • FIGURE 74     U.S. INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY APPLICATION (2019) ($MN)
      • FIGURE 75     REST OF NORTH AMERICA INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY PRODUCT AND INCONTINENCE CARE, BY PRODUCT TYPE (2019 V/S 2026) ($MN)
      • FIGURE 76     REST OF NORTH AMERICA INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY UTILITY AND END-USER (2019 V/S 2026) ($MN)
      • FIGURE 77     REST OF NORTH AMERICA INCONTINENCE AND OSTOMY CARE MARKET REVENUE, APPLICATION (2019) ($MN)
      • FIGURE 78     EUROPE INCONTINENCE AND OSTOMY CARE MARKET SHARE, BY PRODUCT, UTILITY, APPLICATION AND END-USER (2019 V/S 2026)(%)
      • FIGURE 79     EUROPE INCONTINENCE CARE MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) AND DISPOSABLE, ADULT DIAPER, IMPLANT DEVICES, BY TYPE (2019) (%)
      • FIGURE 80     EUROPE INCONTINENCE CARE MARKET SHARE, BY DISEASE TYPE AND OSTOMY CARE, BY SURGERY TYPE (2019 V/S 2026) (%)
      • FIGURE 81     EUROPE OSTOMY CARE MARKET SHARE, BY PRODUCT TYPE AND OSTOMY BAGS, BY TYPE (2019 V/S 2026) (%)
      • FIGURE 82     EUROPE INCONTINENCE AND OSTOMY CARE MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
      • FIGURE 83     GERMANY INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY PRODUCT AND INCONTINENCE CARE, BY PRODUCT TYPE (2019 V/S 2026) ($MN)
      • FIGURE 84     GERMANY INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY UTILITY, AND END-USER (2019 V/S 2026) ($MN)
      • FIGURE 85     GERMANY INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY APPLICATION (2019) ($MN)
      • FIGURE 86     FRANCE INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY PRODUCT AND INCONTINENCE CARE, BY PRODUCT TYPE (2019 V/S 2026) ($MN)
      • FIGURE 87     FRANCE INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY UTILITY AND END-USER (2019 V/S 2026) ($MN)
      • FIGURE 88     FRANCE INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY APPLICATION (2019) ($MN)
      • FIGURE 89     U.K. INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY PRODUCT AND INCONTINENCE CARE, BY PRODUCT TYPE (2019 V/S 2026) ($MN)
      • FIGURE 90     U.K. INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY UTILTY AND END-USER (2019 V/S 2026) ($MN)
      • FIGURE 91     U.K. INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY APPLICATION (2019) ($MN)
      • FIGURE 92     REST OF EUROPE INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY PRODUCT AND INCONTINENCE CARE, BY PRODUCT TYPE (2019 V/S 2026) ($MN)
      • FIGURE 93     REST OF EUROPE INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY UTILITY AND END-USER (2019 V/S 2026) ($MN)
      • FIGURE 94     REST OF EUROPE INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY APPLICATION (2019) ($MN)
      • FIGURE 95     APAC INCONTINENCE AND OSTOMY CARE MARKET SHARE, BY PRODUCT, UTILITY, APPLICATION AND END-USER (2019 V/S 2026) (%)
      • FIGURE 96     APAC INCONTINENCE CARE MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) AND DISPOSABLE, ADULT DIAPER, IMPLANT DEVICES, BY TYPE (2019) (%)
      • FIGURE 97     APAC INCONTINENCE CARE MARKET SHARE, BY DISEASE TYPE AND OSTOMY CARE, BY SURGERY TYPE (2019 V/S 2026) (%)
      • FIGURE 98     APAC OSTOMY CARE MARKET SHARE, BY PRODUCT TYPE AND OSTOMY BAGS, BY TYPE (2019 V/S 2026) (%)
      • FIGURE 99     APAC INCONTINENCE AND OSTOMY CARE MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
      • FIGURE 100     JAPAN INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY PRODUCT AND INCONTINENCE CARE, BY PRODUCT TYPE (2019 V/S 2026) ($MN)
      • FIGURE 101     JAPAN INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY UTILITY AND END-USER (2019 V/S 2026) ($MN)
      • FIGURE 102     JAPAN INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY APPLICATION (2019) ($MN)
      • FIGURE 103     CHINA INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY PRODUCT AND INCONTINENCE CARE, BY PRODUCT TYPE (2019 V/S 2026) ($MN)
      • FIGURE 104     CHINA INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY UTILITY AND END-USER (2019 V/S 2026) ($MN)
      • FIGURE 105     CHINA INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY APPLICATION (2019) ($MN)
      • FIGURE 106     INDIA INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY PRODUCT AND INCONTINENCE CARE, BY PRODUCT TYPE (2019 V/S 2026) ($MN)
      • FIGURE 107     INDIA INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY UTILITY AND END-USER (2019 V/S 2026) ($MN)
      • FIGURE 108     INDIA INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY APPLICATION (2019) ($MN)
      • FIGURE 109     REST OF APAC INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY PRODUCT AND INCONTINENCE CARE, BY PRODUCT TYPE (2019 V/S 2026) ($MN)
      • FIGURE 110     REST OF APAC INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY UTILITY AND END-USER (2019 V/S 2026) ($MN)
      • FIGURE 111     REST OF APAC INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY APPLICATION (2019) ($MN)
      • FIGURE 112     ROW INCONTINENCE AND OSTOMY CARE MARKET SHARE, BY PRODUCT, UTILITY, APPLICATION AND END-USER (2019 V/S 2026) (%)
      • FIGURE 113     ROW INCONTINENCE CARE MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) AND DISPOSABLE, ADULT DIAPER, IMPLANT DEVICES, BY TYPE (2019) (%)
      • FIGURE 114     ROW INCONTINENCE CARE MARKET SHARE, BY DISEASE TYPE AND OSTOMY CARE, BY SURGERY TYPE (2019 V/S 2026) (%)
      • FIGURE 115     ROW OSTOMY CARE MARKET SHARE, BY PRODUCT TYPE AND OSTOMY BAGS, BY TYPE (2019 V/S 2026) (%)
      • FIGURE 116     ROW INCONTINENCE AND OSTOMY CARE MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
      • FIGURE 117     BRAZIL INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY PRODUCT AND INCONTINENCE CARE, BY PRODUCT TYPE (2019 V/S 2026) ($MN)
      • FIGURE 118     BRAZIL INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY UTILITY AND END-USER (2019 V/S 2026) ($MN)
      • FIGURE 119     BRAZIL INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY APPLICATION (2019) ($MN)
      • FIGURE 120     REST OF LATAM INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY PRODUCT AND INCONTINENCE CARE, BY PRODUCT TYPE (2019 V/S 2026) ($MN)
      • FIGURE 121     REST OF LATAM INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY UTILITY AND END-USER (2019 V/S 2026) ($MN)
      • FIGURE 122     REST OF LATAM INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY APPLICATION (2019) ($MN)
      • FIGURE 123     MIDDLE EAST & AFRICA INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY PRODUCT AND INCONTINENCE CARE, BY PRODUCT TYPE (2019 V/S 2026) ($MN)
      • FIGURE 124     MIDDLE EAST & AFRICA INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY UTILITY AND END-USER (2019 V/S 2026) ($MN)
      • FIGURE 125     MIDDLE EAST & AFRICA INCONTINENCE AND OSTOMY CARE MARKET REVENUE, BY APPLICATION (2019) ($MN)
      • FIGURE 126     KEY GROWTH STRATEGIES, (2017-2020) (%)
      • FIGURE 127     SWOT: COLOPLAST A/S
      • FIGURE 128     SWOT: CONVATEC GROUP PLC
      • FIGURE 129     SWOT: DOMTAR CORPORATION
      • FIGURE 130     SWOT: ESSITY AKTIEBOLAG (PUBL)
      • FIGURE 131     SWOT: HOLLISTER INCORPORATED
      • FIGURE 132     SWOT: KIMBERLY-CLARK CORPORATION
      • FIGURE 133     SWOT: MEDTRONIC, PLC.
      • FIGURE 134     SWOT: ONTEX
      • FIGURE 135     SWOT: PAUL HARTMANN AG
      • FIGURE 136     SWOT: UNICHARM CORPORATION

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     3M
      • 2     11 Health and Technologies Limited
      • 3     A.M.I. GmbH
      • 4     Abena AS
      • 5     Adapta Medical, Inc.
      • 6     Affluent Medical SA
      • 7     ALBAAD Massuot Yitzhak LTD
      • 8     ALCARE Co., LTD
      • 9     AmeriDerm Laboratories, LTD
      • 10     Axonics Modulation Technologies, Inc.
      • 11     B. Braun Melsungen Ag
      • 12     Becton, Dickinson And Company
      • 13     Betatech Medical
      • 14     Birchwood Laboratories LLC
      • 15     Bluewind Medical
      • 16     Boston Scientific
      • 17     Bray Group LTD
      • 18     Caldera Medical Inc.
      • 19     Care Corporation
      • 20     Changzhou Medical Appliances General Factory co., LTD
      • 21     Chiaus (Fujian) Industrial Development Co., LTD
      • 22     CL Medical
      • 23     Coloplas A/S
      • 24     ConvaTec Group Plc
      • 25     Cousin Biotech
      • 26     Cymed Ostomy Co
      • 27     Cardinal Health, Inc.
      • 28     Cymed Ostomy Co
      • 29     Daio Paper Corporation
      • 30     Dipro Medical Devices S.R.L.
      • 31     Domtar Corporation
      • 32     Drylock Technologies
      • 33     Elidah, Inc.
      • 34     Essity AB
      • 35     Eurofil Srl
      • 36     Femeda LTD
      • 37     First Quality Enterprises, Inc.
      • 38     Flat-D Innovations Inc.
      • 39     Flexicare Medical LTD
      • 40     Flexiprobe LTD.
      • 41     GT Urological LLC
      • 42     Helioscopie
      • 43     Hengan International
      • 44     Hollister Incorporated
      • 45     Hunter Urology
      • 46     InControl Medical, LLC
      • 47     Implantica Trading Ag
      • 48     Johnson & Johnson (Ethicon)
      • 49     Kamal healthcare products private limited
      • 50     Kimberly-Clark Corporation
      • 51     LABORIE Medical Technologies
      • 52     MacGregor Healthcare LTD
      • 53     Marlen Manufacturing & Development Co.
      • 54     MedGyn Products Inc.
      • 55     Mediplus LTD.
      • 56     Medtronic, Plc
      • 57     Mega disposables S.A.
      • 58     Nobel Hygiene Limited
      • 59     Nu-Hope Labs
      • 60     OakMed LTD
      • 61     Ontex
      • 62     Ostofresh
      • 63     Ostomy Essentials
      • 64     Oxmed International
      • 65     Ostoform LTD.
      • 66     Ostomycure AS
      • 67     Paul Hartmann AG
      • 68     Perfect Choice Medical Technologies
      • 69     Principle Business Enterprises
      • 70     Procter & Gamble Company
      • 71     Resilia Medical Solutions
      • 72     SAEHAN Co., LTD.
      • 73     Safe N Simple LLC
      • 74     Salts Healthcare
      • 75     Securi-T
      • 76     Simavita Limited
      • 77     Sterimed Medical Devices Pvt. LTD
      • 78     TG Eakin Limited
      • 79     THT Bio-science group
      • 80     Tilla Care LTD.
      • 81     Torbot Group Inc.
      • 82     TG Eakin Limited
      • 83     THT Bio-science group
      • 84     Na'Scent
      • 85     Trio Healthcare LTD.
      • 86     Triple W
      • 87     TZMO SA
      • 88     Unicharm Corporation
      • 89     Unique Wellness
      • 90     Uriclak
      • 91     Urocare Products Inc
      • 92     Welland Medical LTD
      • 93     Wiesner Healthcare Innovation LLC
      • 94     Zephyr Surgical Implants